CMC Bottleneck is Choking Biopharma's Drug Pipeline, says Zifo

Summary

Zifo released a position paper identifying Chemistry, Manufacturing, Controls (CMC) as a billion-dollar bottleneck in the biopharma drug pipeline, citing fragmented data, poor scientific handoffs, and outdated technology transfer models as root causes.